ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 248 out of 1107

$628K Total Retail Price of All Prescriptions

Rank: 272 out of 1107

431 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

34% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 5,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 671 256 S3 1 1
LISINOPRIL 415 200 2 2
SIMVASTATIN 403 180 3 5
LEVOTHYROXINE SODIUM 393 191 4 3
METFORMIN HCL 323 157 5 8
GABAPENTIN 315 135 6 9
HYDROCHLOROTHIAZIDE 280 115 7 11
OMEPRAZOLE 225 85 8 4
RANITIDINE HCL 201 110 9 21
NEXIUM 198 96 10 18
POTASSIUM CHLORIDE 197 108 11 14
AMLODIPINE BESYLATE 195 120 12 6
TAMSULOSIN HCL 192 143 13 30
ZOLPIDEM TARTRATE 182 82 14 22
CARVEDILOL 172 55 15 27
GLYBURIDE 160 70 R 16 68
TIZANIDINE HCL 152 35 17 73
SUBOXONE 152 0 17 148
CRESTOR 136 56 19 23
FUROSEMIDE 134 57 20 7
SERTRALINE HCL 129 70 21 20
TRAMADOL HCL 123 24 22 26
MELOXICAM 120 72 23 25
ATORVASTATIN CALCIUM 119 64 24 13
BUMETANIDE 119 86 24 123
ATENOLOL 115 57 26 19
METOPROLOL SUCCINATE 113 78 27 16
IBUPROFEN 111 33 28 63
CITALOPRAM HBR 105 44 29 17
CLOPIDOGREL 101 43 30 28
PAROXETINE HCL 96 55 31 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 60 32 24
LOVAZA 93 19 33 101
SPIRIVA 89 11 34 57
NAPROXEN 89 26 34 80
PREDNISONE 88 51 36 40
METOPROLOL TARTRATE 87 42 37 10
LOSARTAN POTASSIUM 86 71 38 29
AMLODIPINE BESYLATE-BENAZEPRIL 81 54 39 77
SPIRONOLACTONE 79 41 40 72
AMOXICILLIN 78 28 41 90
PROAIR HFA 76 27 42 37
SYNTHROID 75 75 43 70
AMITRIPTYLINE HCL 73 0 R 44 48
PLAVIX 72 28 45 39
PANTOPRAZOLE SODIUM 71 44 46 30
HYDROXYZINE PAMOATE 69 18 R 47 152
ISOSORBIDE MONONITRATE ER 68 38 48 34
PROMETHAZINE HCL 65 17 R 49 44
VYTORIN 64 42 50 169
LEVOFLOXACIN 64 26 50 71
DIOVAN 62 14 52 51
NIASPAN 61 46 53 125
CYCLOBENZAPRINE HCL 59 0 R 54 56
CILOSTAZOL 58 33 55 194
WARFARIN SODIUM 58 48 55 15
SINGULAIR 56 23 57 65
GLIPIZIDE 55 23 58 64
CEPHALEXIN 55 21 58 81
METHYLPREDNISOLONE 54 15 60 119
PRAVASTATIN SODIUM 52 23 61 12
CYMBALTA 51 0 62 50
DIGOXIN 51 30 62 52
LYRICA 50 0 64 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.